After matching , differences in rates of major MR ( MMR , measured as a 3log reduction on the International Scale [ IS ] ) , MR ( 4.0 ) ( 4log reduction on IS ) , and MR ( 4.5 ) ( 4.5 log reduction on IS ) relative to imatinib were indirectly compared between nilotinib and dasatinib .